White label ELPA - ClinicalTrials.eu

Study on the Effects of EP262 for Adults with Chronic Spontaneous Urticaria

Not recruiting

2 1 1
Investigated Diseases:
- Chronic spontaneous urticaria
Investigated Drugs:
- Ep262
Study on Pembrolizumab and Lenvatinib for Patients with Pre-Treated Thymic Carcinoma and B3-Thymoma

Not recruiting

2 1 1 1
Investigated Diseases:
- Thymic carcinoma
- Thymoma
Investigated Drugs:
- Lenvatinib
- Pembrolizumab
Study of Pembrolizumab and Enzalutamide in Patients with Metastatic Hormone-Sensitive Prostate Cancer

Not recruiting

3 1 1
Investigated Diseases:
- Prostate cancer
Investigated Drugs:
- Enzalutamide
- Pembrolizumab
Study on Nicotine Freshmint Mouthspray for E-cigarette Users Looking to Quit

Not recruiting

3 1 1
Investigated Diseases:
- Nicotine dependence
Investigated Drugs:
- Nicotine
Study of Pembrolizumab, Cisplatin, and Gemcitabine for Patients with Muscle-Invasive Bladder Cancer Eligible for Cisplatin Treatment

Not recruiting

3 1 1
Investigated Diseases:
Investigated Drugs:
+4
Study on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials

Not recruiting

4 1 1 1
Investigated Drugs:
- Amlitelimab
+7
Study Comparing Venetoclax and Dexamethasone with Pomalidomide and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Not recruiting

3 1 1 1
Investigated Drugs:
+1
Study on Lenalidomide, Tafasitamab, and Rituximab for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older

Not recruiting

2 1 1 1
Investigated Drugs:
Study on Deucravacitinib for Patients with Active Psoriatic Arthritis New to Biologic Treatments

Not recruiting

3 1
Investigated Diseases:
- Psoriatic arthropathy
Investigated Drugs:
- Deucravacitinib
+4
Study of Venetoclax and Azacitidine for Patients with Acute Myeloid Leukemia After Stem Cell Transplant

Not recruiting

3 1 1 1
Investigated Diseases:
- Acute myeloid leukaemia
Investigated Drugs:
- Azacitidine
- Venetoclax
+1

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies